A new UBCO study finds people are using small doses of psychedelics not for recreational purposes, but to combat anxiety and depression.
Psychedelics used to combat anxiety and depression, not to get high
An international study led by UBC Okanagan researchers suggests repeated use of small doses of psychedelics such as psilocybin or LSD can be a valuable tool for those struggling with anxiety and depression.
The study, recently published in Nature: Scientific Reports, demonstrated fewer symptoms of anxiety and depression, and greater feelings of wellbeing among individuals who reported consuming psychedelics in small quantities, or microdosing, compared to those who did not.
Microdosing involves regular self-administration of psychedelic substances in amounts small enough to not impair normal cognitive functioning.
Considering this is the largest psychedelic microdosing study published to date, the results are encouraging, says UBCO doctoral student and lead author Joseph Rootman.
“In total, we followed more than 8,500 people from 75 countries using an anonymous self-reporting system—about half were following a microdosing regimen and half were not,” Rootman explains. “In comparing microdosers and non-microdosers, there was a clear association between microdosing and fewer symptoms of depression, anxiety and stress—which is important given the high prevalence of these conditions and the substantial suffering they cause.”
The study is also the first to systematically examine the practice of stacking, or combining microdoses of psychedelics with other substances like niacin, lions mane mushrooms and cacao, which some believe work in conjunction to maximize benefit.
Rootman works with Dr. Zach Walsh, a psychology professor in UBCO’s Irving K. Barber Faculty of Arts and Social Sciences. Dr. Walsh says it’s an exciting time for research in this area.
“These findings highlight adults who are microdosing to treat their mental health conditions and enhance their wellbeing—rather than simply to get high,” says Dr. Walsh. “We have an epidemic of mental health problems, with existing treatments that don’t work for everyone. We need to follow the lead of patients who are taking these initiatives to improve their wellbeing and reduce suffering.”
Study co-author Kalin Harvey is the chief technology officer of Quantified Citizen, a mobile health research platform. He says this study highlights the potential of citizen science.
“The use of citizen science allows us to examine the effects of behaviours that are difficult to study in the lab due to regulatory challenges and stigma associated with the now discredited ‘war on drugs.’”
According to the Canadian Mental Health Association, one in five Canadians personally experience a mental health problem or illness each year. This is one of the many reasons Dr. Walsh says conducting innovative psychological research is imperative.
“These cross-sectional findings are promising and highlight the need for further investigation to better determine the impacts of factors like dosage and stacking,” explains Dr. Walsh.
“While the data is growing to support the use of psychedelics like psilocybin in large doses to treat depression and addiction—our data also helps to expand our understanding of how psychedelics may also help in smaller doses.”
Original Article: UBCO study finds psychedelic microdosing improves mental health
More from: University of British Columbia
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Small doses of psychedelics
- Ketamine bros are giving psychedelics a bad rap. That's a problem for those who need them.
I've become unnerved by this ketamine bro culture, which threatens to halt the exciting progress in psychedelic research over the last few decades.
- MindBio Landmark Sleep Research Published in Prestigious Nature Portfolio Journal Translational Psychiatry
MindBio scientist’s sleep research published in prestigious peer reviewed scientific journal MindBio’s proprietary treatment protocol using MB22001, results in longer sleep and better quality of sleep ...
- Beyond Electric Kool-Aid: Santa Cruz emerges as a leader in the psychedelic revolution
In recent years, interest in the potential mental health benefits of psychedelic substances has mushroomed. And Santa Cruz, politically and culturally, has played a leading role in the revolution.
- As California Seeks to Legalize Psychedelics for Therapy, Oregon Provides Key Lessons
Following Gov. Gavin Newsom’s veto last year, lawmakers hope SB 1012 can finally regulate supervised use of psychedelics in California.
- Tiny Doses of LSD Boost Unique Signals in The Human Brain
Even small doses of LSD could have therapeutic ... usually correlating with consciousness levels. High doses of psychedelics can increase complexity, which has been suggested to explain their ...
Go deeper with Google Headlines on:
Small doses of psychedelics
[google_news title=”” keyword=”small doses of psychedelics” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Microdoses of psychedelics
- California should legalize psychedelics but learn from mistakes in marijuana regulation
California policymakers are right to continue to push for psychedelic legalization. Still, they also need to design therapy regulations that ensure legal psychedelic treatments are affordable and ...
- KPIX In Focus: Past and future of psychedelics in California medicine
Elizabeth Cook anchors an in-depth look at the potential benefits of adding mind-altering drugs to California physicians' arsenal of approved treatments. (4-26-24 ...
- Police seize nearly 60 lbs. of psychedelic mushrooms from rental home in quiet metro neighborhood
Investigators say residents there cultivated and grew the magic mushrooms in several rooms of the house and then sold them to drive up customers.
- Ketamine bros are giving psychedelics a bad rap. That's a problem for those who need them.
I've become unnerved by this ketamine bro culture, which threatens to halt the exciting progress in psychedelic research over the last few decades.
- MindBio Landmark Sleep Research Published in Prestigious Nature Portfolio Journal Translational Psychiatry
MindBio scientist’s sleep research published in prestigious peer reviewed scientific journal MindBio’s proprietary treatment protocol using MB22001, results in longer sleep and better quality of sleep ...
Go deeper with Google Headlines on:
Microdoses of psychedelics
[google_news title=”” keyword=”microdoses of psychedelics” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]